Suzhou Industrial Park

Transgene and PersonGen Announce Collaboration to Evaluate a New Combination Therapy Against Solid Tumors

Retrieved on: 
Tuesday, January 18, 2022 - 4:45pm

The collaboration aims to demonstrate the combinations likely synergistic mechanisms to potentiate CAR-T cell therapy.

Key Points: 
  • The collaboration aims to demonstrate the combinations likely synergistic mechanisms to potentiate CAR-T cell therapy.
  • PersonGen will evaluate the efficacy of the combination to eliminate solid tumors in preclinical models.
  • In addition, the high heterogeneity of solid tumors also facilitates immune escape from CAR-T cell therapy.
  • Preclinical studies with TAA06, including pharmacodynamic data have shown superior in vivo and in vitro therapeutic efficacy in solid tumors.

Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization Efforts

Retrieved on: 
Wednesday, January 12, 2022 - 2:15pm

TUCSON, Ariz., Jan. 12, 2022 /PRNewswire/ --Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that it was honored as a recipient of China's Suzhou Industrial Park's (SIP) 15th Science and Technology Leaders Innovation Award for the Company's Accelerate Pheno System.

Key Points: 
  • TUCSON, Ariz., Jan. 12, 2022 /PRNewswire/ --Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that it was honored as a recipient of China's Suzhou Industrial Park's (SIP) 15th Science and Technology Leaders Innovation Award for the Company's Accelerate Pheno System.
  • The award brings further recognition to the Accelerate Pheno System and will help to defray near-term costs to continue commercialization efforts in China.
  • Accelerate Diagnostics, Inc. is anin vitrodiagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis.
  • The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENO TEST" and diamond shaped logos and marks are trademarks or registered trademarks of Accelerate Diagnostics, Inc.
    For more information about the company, its products and technology, or recent publications, visit axdx.com .

Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC

Retrieved on: 
Wednesday, January 12, 2022 - 7:09am

Two phase I trials have been ongoing in both US and China since April 2020.

Key Points: 
  • Two phase I trials have been ongoing in both US and China since April 2020.
  • The IGCC poster will present the data of the TST001 dose-escalation part from this ongoing trial.
  • The ASCO GI poster TPS375 will present the design of the US trial as Trial in Progress.
  • Transcenta (HKEX: 06628) is a clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, development and manufacturing.

SinoMab Awared the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong an

Retrieved on: 
Tuesday, January 11, 2022 - 7:55am

The Company was also previously awarded the "Listed Company with Most Growth Potential" in the selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies".

Key Points: 
  • The Company was also previously awarded the "Listed Company with Most Growth Potential" in the selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies".
  • In addition, SN1011, a key product of the Company, completed its phase I last subject last visit in China in July last year.
  • That reflects the capital market's recognition of the value, management and growth potential of the Company and is a great encouragement to the Company.
  • The selection of the "6th Hong Kong Golden Stocks Awards" was jointly organized by Zhitongcaijing.com, a leading Hong Kong and US stock information platform in China, with RoyalFlush Finance and China Galaxy Securities.

Xinhua Silk Road: 2021 Global AI Product & Application Expo kicks off in Suzhou to boost dev. of AI industry

Retrieved on: 
Wednesday, September 22, 2021 - 4:19am

BEIJING, Sept. 22, 2021 /PRNewswire/ -- The 2021 Global AI Product & Application Expokicked off Thursday in Suzhou of east China's Jiangsu Province, focusing on the latest technological achievements and applications of artificial intelligence (AI).

Key Points: 
  • BEIJING, Sept. 22, 2021 /PRNewswire/ -- The 2021 Global AI Product & Application Expokicked off Thursday in Suzhou of east China's Jiangsu Province, focusing on the latest technological achievements and applications of artificial intelligence (AI).
  • The event will last to September 18, and "AI plus manufacturing", "AI plus medical", "AI plus finance", "AI plus cultural tourism" and other areas with local features of Suzhou will be highlighted.
  • The opening ceremony for the 2021 Global AI Product & Application Expo is held Thursday in Suzhou.
  • The Global AI Product & Application Expo is an important window to display the achievements of China's pilot zones of new-generation AI innovation and development, and has been held in Suzhou for three consecutive years since 2018.

Xinhua Silk Road: 2021 Global AI Product & Application Expo kicks off in Suzhou to boost dev. of AI industry

Retrieved on: 
Wednesday, September 22, 2021 - 3:33am

BEIJING, Sept. 21, 2021 /PRNewswire/ -- The 2021 Global AI Product & Application Expokicked off Thursday in Suzhou of east China's Jiangsu Province, focusing on the latest technological achievements and applications of artificial intelligence (AI).

Key Points: 
  • BEIJING, Sept. 21, 2021 /PRNewswire/ -- The 2021 Global AI Product & Application Expokicked off Thursday in Suzhou of east China's Jiangsu Province, focusing on the latest technological achievements and applications of artificial intelligence (AI).
  • The event will last to September 18, and "AI plus manufacturing", "AI plus medical", "AI plus finance", "AI plus cultural tourism" and other areas with local features of Suzhou will be highlighted.
  • The opening ceremony for the 2021 Global AI Product & Application Expo is held Thursday in Suzhou.
  • The Global AI Product & Application Expo is an important window to display the achievements of China's pilot zones of new-generation AI innovation and development, and has been held in Suzhou for three consecutive years since 2018.

HUYABIO Files an Investigational New Drug Application with the FDA for the Novel SHP2 Inhibitor HBI-2376

Retrieved on: 
Tuesday, August 31, 2021 - 1:05pm

The companies entered into a licensing agreement granting HUYABIO worldwide rights outside China to HBI-2376 prior to filing the regulatory submissions.

Key Points: 
  • The companies entered into a licensing agreement granting HUYABIO worldwide rights outside China to HBI-2376 prior to filing the regulatory submissions.
  • Dr. Mireille Gillings, CEO & Executive Chair of HUYABIO, said, "This submission represents a first filing of simultaneous INDs, to coordinate the development of our SHP2 inhibitor in both the US and China.
  • The senior management team of Genhouse has multiple years of experience in new drug development, clinical research and corporate management.
  • With these platforms, Genhouse has started to build a highly innovative anti-cancer pipeline and out-licensed the ex-China rights of its SHP2 inhibitor GH21 to HUYABIO, an international biotech company.

Baidu World 2021: Baidu Showcases How Latest AI Innovations Transform Transportation, Industry and Daily Life

Retrieved on: 
Wednesday, August 18, 2021 - 4:52pm

BEIJING, Aug.18, 2021 /PRNewswire/ --Today, Baidu demonstrated how its latest AI innovations will transform and improve transportation, industry and daily life at its annual flagship technology conference, Baidu World 2021.

Key Points: 
  • BEIJING, Aug.18, 2021 /PRNewswire/ --Today, Baidu demonstrated how its latest AI innovations will transform and improve transportation, industry and daily life at its annual flagship technology conference, Baidu World 2021.
  • Speaking on how Baidu is doing this with AI, Baidu Co-founder and CEO Robin Li said, "AI is the combination of technology and feeling.
  • AI-powered search with Baidu APP Baidu demonstrated onstage how AI technology powers speech recognition search on its Baidu APP, which has 580 million monthly active users.
  • Upgrading industries with AI technology Baidu AI Cloud has seen strong growth, growing 71% year over year as reported in Baidu's Q2 2021 Earnings Report.

The 13th Venture Week for International Elites was held in Suzhou

Retrieved on: 
Monday, July 12, 2021 - 1:54pm

SUZHOU, China, July 12, 2021 /PRNewswire/ --On July 10, 2021 (13th) Venture Week for International Elites in Suzhou and the 2nd Suzhou Scientists Day opened at Suzhou International Expo Center.

Key Points: 
  • SUZHOU, China, July 12, 2021 /PRNewswire/ --On July 10, 2021 (13th) Venture Week for International Elites in Suzhou and the 2nd Suzhou Scientists Day opened at Suzhou International Expo Center.
  • This year's Venture Week attracted 78 academicians to attend the event, more than 3,000 talented guests participated in the event, and a total of 3139 projects participated in the docking, according to the Organizing Committee of the Venture Week.
  • Venture Week is a major talent recruitment activity that Suzhou focuses on.
  • The Venture Week was carried out in the form of a combination of online and offline.

XJTLU Celebrates its Past by Embarking on the Future

Retrieved on: 
Thursday, May 20, 2021 - 11:20am

It boasts approximately 900 staff from 50 countries and regions.

Key Points: 
  • It boasts approximately 900 staff from 50 countries and regions.
  • "The future of education is not focused on teachers imparting knowledge to students, but instead on how educational institutions will support lifelong learning," says Dr Xiaojun Zhang, Executive Dean of the Academy.\nTo provide tools for all learners, XJTLU and the Academy of Future Education will open the XJTLU Learning Mall to the public on Saturday, one year after its launch to University staff and students.
  • Available offerings at www.learningmall.cn continue to grow, with partners including Adobe, Microsoft, McGraw-Hill Group, Alibaba Cloud and Digital China providing educational content, training and online certification tests.\nXJTLU\'s Academy of Film and Creative Technology also will launch Saturday.
  • "Partnering with media and creative industries will enable us to meet industry needs and train students and professionals to be cultural and creative industry leaders," says Professor Stuart Perrin, Associate Principal of XJTLU Entrepreneur College (Taicang).\n'